The USA's Institute for Clinical and Economic Review (ICER) has released a Final Evidence Report assessing the comparative ...

China-based Jiangsu Hengrui Pharma and US start-up Kailera Therapeutics, which is advancing a broad pipeline of ...

UK-based ViiV Healthcare, the HIV specialist company majority owned by GSK, with Pfizer and Shionogi as shareholders, has announced data from the Phase IIIb VOLITION study.

Russia will begin commercial production of a new anticancer vaccine, which massive supplies for the needs of domestic ...

In the USA, the 340B hospital markup program cost state and federal taxpayers an estimated $6.5 billion per year due to lost ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has today approved Ekterly (sebetralstat) 0for the ...

Japanese drugmaker Otsuka Pharmaceutical (TYO: 4578) has signed a deal to acquire Cantargia’s CAN10 program in a transaction worth up to $613 million. The move hands Otsuka global rights to an ...

The Bristol Myers Squibb subsidiary RayzeBio has opened a new 77,000-square-foot facility in Indianapolis, Indiana.

US biotech Tract Bio has appointed Chris Galloway as chief medical and development officer, as it prepares for an ...

If approved, MCO-010 would be the first treatment to restore vision in legally blind RP patients without needing genetic ...

Swiss clinical-stage CNS disease specialist Synendos Therapeutics has named Dr George Garibaldi as its chief medical officer ...

USA-based Uniquity Bio has appointed industry veteran Will Kane as its president and chief executive. The clinical-stage drug ...